Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
4
57%
Ph phase_3
1
14%
Ph phase_2
1
14%

Phase Distribution

4

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Other(1)

Detailed Status

Completed5
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (66.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)

Trials by Status

active_not_recruiting114%
completed571%
unknown114%

Recent Activity

1 active trials
Showing 5 of 7
active_not_recruitingphase_2

ZN-c3 + Gemcitabine in Pancreatic Cancer

NCT06015659
completedphase_1

A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer

NCT06278493
completedphase_1

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

NCT01547260
unknownphase_1

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

NCT02975141
completedphase_1

Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

NCT01674556
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06015659Phase 2

ZN-c3 + Gemcitabine in Pancreatic Cancer

Active Not Recruiting
NCT06278493Phase 1

A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer

Completed
NCT01547260Phase 1

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

Completed
NCT02975141Phase 1

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer

Unknown
NCT01674556Phase 1

Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

Completed
NCT00419042

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed
NCT00035035Phase 3

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7